Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBruno Paiva, Jesús F. San Miguel, María‐Belén Vídriales et al.|Blood|2008Cited by 479
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquín Martínez‐López, Ramón García‐Sánz, Cristina Jiménez et al.|Blood|2014Cited by 429
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patientsBruno Paiva, María‐Belén Vídriales, Gema Mateo et al.|Blood|2009Cited by 75
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular responsePilar Martínez‐Sánchez, Joaquín Martínez‐López, Laura Montejano et al.|British Journal of Haematology|2008Cited by 58
Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐<scp>PCR</scp>of immunoglobulin genes in multiple myeloma. Results from a<scp>GEM</scp>/<scp>PETHEMA</scp>studyJoaquín Martínez‐López, Elena Fernández‐Redondo, Ramón García‐Sánz et al.|British Journal of Haematology|2013Cited by 29